Back
AstraZeneca
AZN
Stock price
$ 66.59
Expected price
$80.5
Returns for 6 months
-2.16%
More
Overview
Value dynamics
6 months
$
About Company AstraZeneca
AstraZeneca Plc is a holding company that researches, develops and manufactures pharmaceutical products. Its pipelines are used in the following therapeutic areas: oncology, cardiovascular, renal, metabolism and respiratory. The company was founded on 17 June 1992 and is headquartered in Cambridge, UK.
Why is it worth investing?
The company reported very positive results in a clinical trial of the breast cancer drug Enhertu.
AstraZeneca started to make profit from vaccines. The company is gradually moving away from the non-profit model it used to follow. The vaccine started to bring profit in the 3rd quarter of 2021, and profits will grow going forward. The company plans to create a special unit to place its COVID-19-related assets, which will affect future profits.
In July 2021, the company completed the acquisition of Alexion Pharmaceuticals. Five approved drugs will be added to the issuer's portfolio, which will increase the company's revenue by ~ USD 6.5 billion. Alexion management expects to launch 10 more potential products by 2023, which will allow AstraZeneca to increase revenue significantly over the next 10 years.
